Unit name | Neurodegeneration and Ophthalmic Disorders |
---|---|
Unit code | CSSBM1012 |
Credit points | 20 |
Level of study | M/7 |
Teaching block(s) |
Academic Year (weeks 1 - 52) |
Unit director | Dr. Caldwell |
Open unit status | Not open |
Pre-requisites |
None |
Co-requisites |
None |
School/department | Bristol Medical School |
Faculty | Faculty of Health Sciences |
The aim of this unit is to introduce neurodegenrative disorders and how stem cells & regenerative medicine approaches are being developed as therapies for these. Content will cover basic science, such as producing specific types of neural cell from stem cells in vitro to the endogenous response to CNS injury through to pre-clinical and clinical applications.
This unit will describe: 1) The pathology of Stroke, Parkinson's, Huntington's and degenerative eye diseases. 2) Neural differentiation of stem cells in vitro and in vivo. 3) Basic research in models of these diseases. 4) Current clinical status or these therapies. 5) Streamed video of immunohistochemistry and microscopy techniques in vitro and in vivo.
Students successfully completing this module will:
Summative Assessment:
Please note that students will be given formative feedback on coursework assessment where appropriate.
Contribution reflects time spent in each exam (2hrs essay, 1hr MCQ).
The pass-mark for the module will be 50%. However students will be required to reach a minimum standard in both their coursework and their written exam. As such only 5% compensation between the total coursework element and the total exam element will be allowed.
For each lecture, seminar, tutorial students will be given a reading list composed of journal and review articles, websites and book chapters. Due to the novelty of this field and the postgraduate nature of this programme we do not feel there are suitable textbooks to recommend for this module.